> top > docs > PMC:7341464 > annotations

PMC:7341464 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 14-22 SP_7 denotes COVID-19
T2 71-80 SP_7 denotes SARS-CoV2
T3 200-208 SP_7 denotes COVID-19
T4 234-241 CL:0000763 denotes myeloid
T5 287-295 SP_7 denotes COVID-19
T6 676-684 SP_7 denotes COVID-19
T7 723-728 UBERON:0007023 denotes adult
T8 752-757 UBERON:0007023 denotes adult
T9 780-789 SP_7 denotes SARS-CoV2
T10 810-818 SP_7 denotes COVID-19
T11 1041-1046 UBERON:0007023 denotes adult
T12 1614-1622 SP_7 denotes COVID-19
T13 1745-1753 SP_7 denotes COVID-19
T14 1849-1855 GO:0007631 denotes intake
T15 2500-2511 NCBITaxon:11118 denotes coronavirus
T16 2748-2753 UBERON:0002398 denotes hands
T17 2774-2779 UBERON:0002398 denotes hands
T18 2836-2844 SP_7 denotes COVID-19
T19 2911-2919 SP_7 denotes COVID-19
T20 2994-3002 SP_7 denotes COVID-19
T21 3080-3088 SP_7 denotes COVID-19
T22 3200-3211 NCBITaxon:11118 denotes coronavirus
T24 3809-3818 SP_7 denotes SARS-CoV2
T25 4009-4017 CHEBI:45783;CHEBI:45783 denotes imatinib
T26 4218-4226 SP_7 denotes COVID-19
T27 4463-4467 UBERON:0001456 denotes face
T28 4864-4873 SP_7 denotes SARS-CoV2
T29 4915-4921 UBERON:0000473 denotes Tested
T30 5093-5098 UBERON:0007023 denotes adult
T31 5400-5408 SP_7 denotes COVID-19
T34 5945-5954 SP_7 denotes SARS-CoV2
T35 6358-6366 SP_7 denotes COVID-19
T36 6638-6649 NCBITaxon:11118 denotes coronavirus
T37 6786-6795 SP_7 denotes SARS-CoV2
T38 6796-6801 NCBITaxon:10239 denotes viral
T39 7281-7289 SP_7 denotes COVID-19
T40 7955-7964 SP_7 denotes SARS-CoV2
T41 8171-8180 SP_7 denotes SARS-CoV2
T42 8233-8241 SP_7 denotes COVID-19
T43 8290-8296 UBERON:0001005 denotes airway
T44 8419-8427 SP_7 denotes COVID-19
T41113 14-22 SP_7 denotes COVID-19
T282 71-80 SP_7 denotes SARS-CoV2
T19915 200-208 SP_7 denotes COVID-19
T97968 234-241 CL:0000763 denotes myeloid
T48759 287-295 SP_7 denotes COVID-19
T18992 676-684 SP_7 denotes COVID-19
T93728 723-728 UBERON:0007023 denotes adult
T73818 752-757 UBERON:0007023 denotes adult
T25523 780-789 SP_7 denotes SARS-CoV2
T44331 810-818 SP_7 denotes COVID-19
T59025 1041-1046 UBERON:0007023 denotes adult
T12693 1614-1622 SP_7 denotes COVID-19
T93541 1745-1753 SP_7 denotes COVID-19
T90775 1849-1855 GO:0007631 denotes intake
T91107 2500-2511 NCBITaxon:11118 denotes coronavirus
T37926 2748-2753 UBERON:0002398 denotes hands
T65523 2774-2779 UBERON:0002398 denotes hands
T26976 2836-2844 SP_7 denotes COVID-19
T91672 2911-2919 SP_7 denotes COVID-19
T48204 2994-3002 SP_7 denotes COVID-19
T41126 3080-3088 SP_7 denotes COVID-19
T6820 3200-3211 NCBITaxon:11118 denotes coronavirus
T70513 3809-3818 SP_7 denotes SARS-CoV2
T92402 4009-4017 CHEBI:45783;CHEBI:45783 denotes imatinib
T20974 4218-4226 SP_7 denotes COVID-19
T88967 4463-4467 UBERON:0001456 denotes face
T28626 4864-4873 SP_7 denotes SARS-CoV2
T93531 4915-4921 UBERON:0000473 denotes Tested
T59311 5093-5098 UBERON:0007023 denotes adult
T51667 5400-5408 SP_7 denotes COVID-19
T32 6358-6366 SP_7 denotes COVID-19
T80344 6358-6366 SP_7 denotes COVID-19
T88389 6638-6649 NCBITaxon:11118 denotes coronavirus
T32342 6786-6795 SP_7 denotes SARS-CoV2
T73672 6796-6801 NCBITaxon:10239 denotes viral
T84389 7281-7289 SP_7 denotes COVID-19
T22107 7955-7964 SP_7 denotes SARS-CoV2
T77654 8171-8180 SP_7 denotes SARS-CoV2
T85367 8233-8241 SP_7 denotes COVID-19
T27737 8290-8296 UBERON:0001005 denotes airway
T76221 8419-8427 SP_7 denotes COVID-19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 4463-4467 Body_part denotes face http://purl.org/sig/ont/fma/fma24728
T2 4756-4762 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 2748-2753 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T2 2774-2779 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T3 4398-4403 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T4 4427-4432 Body_part denotes hands http://purl.obolibrary.org/obo/UBERON_0002398
T5 4463-4467 Body_part denotes face http://purl.obolibrary.org/obo/UBERON_0001456
T6 4756-4762 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 14-22 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 42-45 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T4 71-75 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 200-208 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 253-256 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T8 287-295 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 310-313 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T11 676-684 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 729-732 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T14 780-784 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T15 810-818 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 978-981 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T18 1238-1241 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T20 1614-1622 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 1693-1696 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T23 1737-1740 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T25 1745-1753 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 1995-1998 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T28 2307-2310 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T30 2400-2409 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T31 2451-2454 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T33 2836-2844 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T34 2911-2919 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T35 2931-2934 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T37 2994-3002 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T38 3014-3017 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T40 3080-3088 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 3123-3126 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T43 3392-3400 Disease denotes rhinitis http://purl.obolibrary.org/obo/MONDO_0003014
T44 3588-3596 Disease denotes rhinitis http://purl.obolibrary.org/obo/MONDO_0003014
T45 3809-3813 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T46 4036-4039 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T48 4218-4226 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T49 4230-4233 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T51 4692-4700 Disease denotes Rhinitis http://purl.obolibrary.org/obo/MONDO_0003014
T52 4751-4762 Disease denotes Sore throat http://purl.obolibrary.org/obo/MONDO_0002258
T53 4864-4868 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T54 5167-5176 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T55 5400-5408 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T56 5945-5949 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T57 6358-6366 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T58 6370-6373 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T60 6511-6514 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T62 6786-6790 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T63 6796-6815 Disease denotes viral infections in http://purl.obolibrary.org/obo/MONDO_0005108
T64 6816-6819 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T66 7281-7289 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T67 7290-7299 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T68 7314-7317 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T70 7901-7908 Disease denotes anxiety http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918
T72 7955-7959 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T73 8099-8102 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T75 8171-8175 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T76 8181-8190 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T77 8194-8197 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T79 8233-8241 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 8370-8373 Disease denotes CML http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996
T82 8419-8427 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 8428-8437 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 91-92 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 171-173 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T3 171-173 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T4 507-508 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 581-582 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 927-932 http://purl.obolibrary.org/obo/CLO_0001236 denotes 2], a
T7 961-968 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T8 1116-1117 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1209-1212 http://purl.obolibrary.org/obo/CLO_0001562 denotes a 2
T10 1209-1212 http://purl.obolibrary.org/obo/CLO_0001563 denotes a 2
T11 1285-1286 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T12 1431-1438 http://www.ebi.ac.uk/efo/EFO_0000881 denotes digital
T13 1769-1770 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 1833-1841 http://purl.obolibrary.org/obo/CLO_0009985 denotes focusing
T15 1878-1885 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T16 1991-1994 http://purl.obolibrary.org/obo/CLO_0001079 denotes 148
T17 2052-2054 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T18 2056-2061 http://purl.obolibrary.org/obo/UBERON_0003101 denotes males
T19 2056-2061 http://www.ebi.ac.uk/efo/EFO_0000970 denotes males
T20 2327-2328 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 2498-2499 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 2950-2953 http://purl.obolibrary.org/obo/CLO_0001079 denotes 148
T23 3030-3032 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T24 3235-3236 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T25 3262-3263 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T26 3274-3276 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T27 3798-3804 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T28 3851-3857 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T29 3960-3961 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T30 3970-3974 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T31 3970-3974 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T32 4085-4091 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T33 4271-4274 http://purl.obolibrary.org/obo/CLO_0001079 denotes 148
T34 4380-4381 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T35 4417-4418 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T36 4452-4453 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T37 4463-4467 http://purl.obolibrary.org/obo/UBERON_0001456 denotes face
T38 4483-4484 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T39 4551-4552 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T40 4625-4626 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T41 4656-4657 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T42 4672-4674 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T43 4678-4679 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T44 4716-4718 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T45 4874-4881 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T46 4884-4890 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Tested
T47 4915-4921 http://purl.obolibrary.org/obo/UBERON_0000473 denotes Tested
T48 4950-4956 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T49 5872-5873 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T50 5934-5940 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T51 5985-5991 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T52 6423-6429 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T53 6443-6446 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T54 6845-6847 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T55 6845-6847 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T56 6867-6868 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T57 6990-6996 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T58 7023-7025 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T59 7023-7025 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T60 7061-7062 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T61 7170-7177 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T62 7259-7267 http://purl.obolibrary.org/obo/CLO_0009985 denotes focusing
T63 7505-7512 http://www.ebi.ac.uk/efo/EFO_0000881 denotes digital
T64 7544-7545 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T65 7620-7621 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T66 7772-7773 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 7821-7828 http://purl.obolibrary.org/obo/CLO_0009985 denotes focused
T68 7965-7971 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T69 8048-8050 http://purl.obolibrary.org/obo/CLO_0001022 denotes Li
T70 8048-8050 http://purl.obolibrary.org/obo/CLO_0007314 denotes Li
T71 8161-8162 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 8290-8296 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T73 8334-8339 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus
T74 8355-8362 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T75 8388-8399 http://purl.obolibrary.org/obo/BFO_0000030 denotes objectively

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 171-173 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T2 524-529 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T3 1099-1104 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T4 3970-3974 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T5 4009-4017 Chemical denotes imatinib http://purl.obolibrary.org/obo/CHEBI_45783
T6 5266-5272 Chemical denotes corona http://purl.obolibrary.org/obo/CHEBI_37409
T7 6845-6847 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T8 7023-7025 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145
T9 7782-7787 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T10 7925-7930 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T11 8048-8050 Chemical denotes Li http://purl.obolibrary.org/obo/CHEBI_30145

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 6796-6812 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-90 Sentence denotes Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic.
T2 91-117 Sentence denotes A prospective cohort study
T3 119-133 Sentence denotes To the Editor:
T4 134-262 Sentence denotes We read with interest the article by Li et al. first to report on COVID-19 in patients with chronic myeloid leukaemia (CML) [1].
T5 263-425 Sentence denotes They found an increased COVID-19 prevalence in CML patients of the Hubei region in China when compared to the prevalence of the general population of that region.
T6 426-547 Sentence denotes Unfortunately, in this retrospective study, follow-up data were not provided and a direct control group was not included.
T7 548-876 Sentence denotes We report preliminary results of a prospective Dutch observational cohort study that assessed differences in susceptibility for COVID-19 and severity of the disease course in adult CML patients and their adult housemates during the SARS-CoV2 pandemic (the first COVID-19 case was identified on February 27th in the Netherlands).
T8 877-1020 Sentence denotes Patients were invited to participate via CMyLife [2], a nationwide web-based portal focused on Dutch CML patients, from April 6th 2020 onwards.
T9 1021-1166 Sentence denotes If available, their adult housemates (e.g., spouses) were included as control group, providing a better representation of the general population.
T10 1167-1237 Sentence denotes Surveys were performed at baseline and at a 2-weekly follow-up period.
T11 1238-1354 Sentence denotes CML patients receiving TKI treatment or having a discontinuation of their TKI treatment were invited to participate.
T12 1355-1501 Sentence denotes The study was approved by the Radboudumc institutional ethics committee and digital informed consent was obtained from both patients and partners.
T13 1502-1754 Sentence denotes At inclusion, information was gathered on demographics, self-reported comorbidity, vaccinations, health rating, COVID-19 related symptoms and hospital admissions and additional for patients; CML course, patients’ perceptions regarding CML and COVID-19.
T14 1755-1920 Sentence denotes Every 2 weeks a truncated shorter version of the questionnaire was conducted, focusing on TKI intake, preventive measures, testing, symptoms and hospital admissions.
T15 1921-2167 Sentence denotes At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing.
T16 2168-2236 Sentence denotes The baseline characteristics are presented in Supplementary Table 1.
T17 2237-2280 Sentence denotes The majority (88.4%) had taken TKI therapy.
T18 2281-2388 Sentence denotes Approximately half of the CML patients versus a third of controls had comorbidity that required medication.
T19 2389-2494 Sentence denotes The annual influenza vaccination was received by 58.0% of the CML patients and 35.8% of their housemates.
T20 2495-2649 Sentence denotes If a coronavirus vaccine would become available, both patients and their housemates would be largely willing to take this (76.3% and 68.9%, respectively).
T21 2650-2803 Sentence denotes The majority applied preventive measures as recommended by national institutes (e.g., not shaking hands, frequently washing hands and social distancing).
T22 2804-2866 Sentence denotes Patients’ perceptions regarding COVID-19 are shown in Table 1.
T23 2867-2935 Sentence denotes Table 1 Reported perceptions of patients on COVID-19 related to CML.
T24 2936-2954 Sentence denotes Patients (N = 148)
T25 2955-2960 Sentence denotes % (n)
T26 2961-3017 Sentence denotes Thinks to be more susceptible to COVID-19 because of CML
T27 3018-3033 Sentence denotes   Yes 32.4 (48)
T28 3034-3048 Sentence denotes   No 35.8 (53)
T29 3049-3072 Sentence denotes   Do not know 31.8 (47)
T30 3073-3126 Sentence denotes Thinks COVID-19 course will be more severe due to CML
T31 3127-3142 Sentence denotes   Yes 35.8 (53)
T32 3143-3157 Sentence denotes   No 20.3 (30)
T33 3158-3181 Sentence denotes   Do not know 43.9 (65)
T34 3182-3211 Sentence denotes Worries about the coronavirus
T35 3212-3232 Sentence denotes   Not at all 5.4 (8)
T36 3233-3253 Sentence denotes   A little 54.7 (81)
T37 3254-3277 Sentence denotes   Quite a bit 30.4 (45)
T38 3278-3298 Sentence denotes   Very much 9.5 (14)
T39 3299-3375 Sentence denotes Next we analysed symptoms of patients and housemates at inclusion (Table 2).
T40 3376-3490 Sentence denotes Among patients, rhinitis was the most reported symptom (16.9%), followed by coughing (14.2%) and dyspnoea (10.8%).
T41 3491-3514 Sentence denotes Fever was not reported.
T42 3515-3565 Sentence denotes Many (69.6%) patients reported to be symptom free.
T43 3566-3685 Sentence denotes Among the housemates, rhinitis was reported in 8.9% of cases, and coughing and dyspnoea in 6.5% and 2.4%, respectively.
T44 3686-3716 Sentence denotes Again, fever was not reported.
T45 3717-3770 Sentence denotes The majority (84.6%) reported to be free of symptoms.
T46 3771-3942 Sentence denotes Only two patients had been tested for SARS-CoV2 at study inclusion, of whom one tested positive and reported to have been admitted to the hospital (without ICU admission).
T47 3943-4065 Sentence denotes This patient was a 62 year male without comorbidity, who received imatinib therapy since the CML diagnosis 2 years before.
T48 4066-4129 Sentence denotes No housemates were tested nor reported any hospital admissions.
T49 4130-4256 Sentence denotes Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion.
T50 4257-4296 Sentence denotes Patients (N = 148) Housemates (N = 124)
T51 4297-4308 Sentence denotes % (n) % (n)
T52 4309-4347 Sentence denotes Visited affected areaa 3.4 (5) 4.1 (5)
T53 4348-4368 Sentence denotes Preventive measuresb
T54 4369-4381 Sentence denotes   None 0 N/A
T55 4382-4418 Sentence denotes   Avoid shaking hands 85.1 (126) N/A
T56 4419-4453 Sentence denotes   Clean hands often 84.5 (125) N/A
T57 4454-4484 Sentence denotes   Use of face mask 2.7 (4) N/A
T58 4485-4552 Sentence denotes   Working from home, just as same-function colleagues 31.8 (47) N/A
T59 4553-4626 Sentence denotes   Working from home, in contrary to same-function colleagues 6.8 (10) N/A
T60 4627-4657 Sentence denotes   Self-isolation 41.2 (61) N/A
T61 4658-4679 Sentence denotes   Other 14.9 (22) N/A
T62 4680-4689 Sentence denotes Symptomsb
T63 4690-4719 Sentence denotes   Rhinitis 16.9 (25) 8.9 (11)
T64 4720-4748 Sentence denotes   Coughing 14.2 (21) 6.5 (8)
T65 4749-4778 Sentence denotes   Sore throat 4.1 (6) 2.4 (3)
T66 4779-4807 Sentence denotes   Dyspnoea 10.8 (16) 2.4 (3)
T67 4808-4827 Sentence denotes   Fever 0 (0) 0 (0)
T68 4828-4863 Sentence denotes   No symptoms 69.6 (103) 84.6 (104)
T69 4864-4881 Sentence denotes SARS-CoV2 testing
T70 4882-4912 Sentence denotes   Tested, positive 0.7 (1) 0.0
T71 4913-4943 Sentence denotes   Tested, negative 0.7 (1) 0.0
T72 4944-4977 Sentence denotes   Not tested 98.0 (145) 100 (123)
T73 4978-4997 Sentence denotes   Unknown 0.7 (1) 0
T74 4998-5033 Sentence denotes Hospital admissionc 0.7 (1) 0.0 (0)
T75 5034-5081 Sentence denotes   Intensive Care Unit admission 0.0 (0) 0.0 (0)
T76 5082-5121 Sentence denotes Lives with adult housemate 85.9 (128) –
T77 5122-5137 Sentence denotes N = 131 N = 106
T78 5138-5149 Sentence denotes % (n) % (n)
T79 5150-5158 Sentence denotes Vaccines
T80 5159-5188 Sentence denotes  Annual influenza vaccination
T81 5189-5214 Sentence denotes   Yes 58.0 (76) 35.8 (38)
T82 5215-5239 Sentence denotes   No 42.0 (55) 64.1 (68)
T83 5240-5280 Sentence denotes  If available, would take corona vaccine
T84 5281-5308 Sentence denotes    Yes 76.3 (100) 68.9 (73)
T85 5309-5330 Sentence denotes    No 3.8 (5) 0.9 (1)
T86 5331-5365 Sentence denotes    Do not know 19.8 (26) 30.2 (32)
T87 5366-5484 Sentence denotes aAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment:
T88 5485-5573 Sentence denotes Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran.
T89 5574-5601 Sentence denotes bMultiple answers possible.
T90 5602-5693 Sentence denotes cHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever.
T91 5694-5815 Sentence denotes Currently, most subjects have completed their first and second 2-weekly follow-up questionnaires (Supplementary Table 2).
T92 5816-5871 Sentence denotes No patients reported (temporarily) TKI discontinuation.
T93 5872-6001 Sentence denotes A further six persons (two patients and four housemates) were tested for SARS-CoV2 during this follow-up and all tested negative.
T94 6002-6039 Sentence denotes No hospital admissions were reported.
T95 6040-6197 Sentence denotes At 2 weeks, 74.2% (n = 95) of the patients reported to be free of symptoms, compared to 79.4% (n = 100) and 88.9% (n = 16) at four and 6 weeks, respectively.
T96 6198-6294 Sentence denotes For housemates these rates were 87.6% (n = 106), 91.6% (n = 98) and 100% (n = 15), respectively.
T97 6295-6383 Sentence denotes To conclude, we found no significantly increased prevalence of COVID-19 in CML patients.
T98 6384-6477 Sentence denotes Only one patient (0.7%) reported to be tested positive and has been admitted to the hospital.
T99 6478-6650 Sentence denotes These findings are important for CML patients and professionals (prescribers of TKI) as almost 40% of patients reported to be substantially concerned about the coronavirus.
T100 6651-6854 Sentence denotes The prevalence rate is in line with the reported 0.3% in the general Dutch population [3], and with the reported low prevalence of <1% SARS-CoV2 viral infections in CML patients in the study of Li et al.
T101 6855-7011 Sentence denotes We included a representative control cohort of housemates of similar age and geographical spreading as the patients, of whom none were tested positive (0%).
T102 7012-7244 Sentence denotes Similar to Li et al. (0.9% vs 0.1%), we did find a slightly higher percentage of infected patients than in the general population (0.7% vs 0.3%) based on PCR testing on clinical indication, but this is not statistically significant.
T103 7245-7341 Sentence denotes Other studies focusing primarily on COVID-19 infection prevalence in CML population are lacking.
T104 7342-7391 Sentence denotes There are strengths and limitations to our study.
T105 7392-7713 Sentence denotes Although there may have been some self-selection bias in our study, the recruitment through the national CMyLife digital patient platform did allow for a substantial and geographically nationwide spread of participants, also in a time when many patients isolated themselves and hospital visits were limited when possible.
T106 7714-7788 Sentence denotes Also, our study was performed prospectively, and included a control group.
T107 7789-7931 Sentence denotes Furthermore, our questionnaires focused on patients’ perceptions, offering insights in the substantial level of anxiety in this patient group.
T108 7932-8017 Sentence denotes However, the number of SARS-CoV2 tested subjects was low, limiting statistical power.
T109 8018-8251 Sentence denotes Taken together, the report by Li et al. and our current data may offer relief to CML patients in general that the absolute risk of contracting a serious SARS-CoV2 infection in CML patients, was low (<1%) during the COVID-19 pandemic.
T110 8252-8449 Sentence denotes However, as we did observe more upper airway symptoms and further research should focus on serological testing in the CML population to objectively assess subclinical COVID-19 infection prevalence.
T111 8450-8522 Sentence denotes Finally, our study supports that patients can safely continue their TKI.
T112 8524-8549 Sentence denotes Supplementary information
T113 8551-8570 Sentence denotes Supplemental Tables
T114 8572-8707 Sentence denotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
T115 8709-8734 Sentence denotes Supplementary information
T116 8735-8870 Sentence denotes The online version of this article (10.1038/s41375-020-0964-0) contains supplementary material, which is available to authorized users.
T117 8872-8892 Sentence denotes Author contributions
T118 8893-9109 Sentence denotes GICGE and PEW designed the study; GICGE analysed the data; GICGE wrote the paper with contributions from all authors, who also interpreted the data, and read, commented on and approved the final version of the paper.
T119 9111-9144 Sentence denotes Compliance with ethical standards
T120 9146-9166 Sentence denotes Conflict of interest
T121 9167-9226 Sentence denotes The authors declare that they have no conflict of interest.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 234-251 Phenotype denotes myeloid leukaemia http://purl.obolibrary.org/obo/HP_0012324
T2 3392-3400 Phenotype denotes rhinitis http://purl.obolibrary.org/obo/HP_0012384
T3 3452-3460 Phenotype denotes coughing http://purl.obolibrary.org/obo/HP_0012735
T4 3473-3481 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T5 3491-3496 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T6 3588-3596 Phenotype denotes rhinitis http://purl.obolibrary.org/obo/HP_0012384
T7 3632-3640 Phenotype denotes coughing http://purl.obolibrary.org/obo/HP_0012735
T8 3645-3653 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T9 3693-3698 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T10 4692-4700 Phenotype denotes Rhinitis http://purl.obolibrary.org/obo/HP_0012384
T11 4722-4730 Phenotype denotes Coughing http://purl.obolibrary.org/obo/HP_0012735
T12 4751-4762 Phenotype denotes Sore throat http://purl.obolibrary.org/obo/HP_0033050
T13 4781-4789 Phenotype denotes Dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T14 4810-4815 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T15 5661-5669 Phenotype denotes coughing http://purl.obolibrary.org/obo/HP_0012735
T16 5671-5679 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T17 5687-5692 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T18 7901-7908 Phenotype denotes anxiety http://purl.obolibrary.org/obo/HP_0000739

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
4 46-54 Species denotes patients Tax:9606
5 71-80 Species denotes SARS-CoV2 Tax:2697049
6 14-22 Disease denotes COVID-19 MESH:C000657245
7 42-45 Disease denotes CML MESH:D015464
15 212-220 Species denotes patients Tax:9606
16 314-322 Species denotes patients Tax:9606
17 200-208 Disease denotes COVID-19 MESH:C000657245
18 226-251 Disease denotes chronic myeloid leukaemia MESH:C580075
19 253-256 Disease denotes CML MESH:D015464
20 287-295 Disease denotes COVID-19 MESH:C000657245
21 310-313 Disease denotes CML MESH:D015464
30 733-741 Species denotes patients Tax:9606
31 780-789 Species denotes SARS-CoV2 Tax:2697049
32 877-885 Species denotes Patients Tax:9606
33 982-990 Species denotes patients Tax:9606
34 676-684 Disease denotes COVID-19 MESH:C000657245
35 729-732 Disease denotes CML MESH:D015464
36 810-818 Disease denotes COVID-19 MESH:C000657245
37 978-981 Disease denotes CML MESH:D015464
41 1242-1250 Species denotes patients Tax:9606
42 1479-1487 Species denotes patients Tax:9606
43 1238-1241 Disease denotes CML MESH:D015464
50 1683-1691 Species denotes patients Tax:9606
51 1705-1713 Species denotes patients Tax:9606
52 1614-1622 Disease denotes COVID-19 MESH:C000657245
53 1693-1696 Disease denotes CML MESH:D015464
54 1737-1740 Disease denotes CML MESH:D015464
55 1745-1753 Disease denotes COVID-19 MESH:C000657245
59 1948-1956 Species denotes patients Tax:9606
60 1999-2007 Species denotes patients Tax:9606
61 1995-1998 Disease denotes CML MESH:D015464
68 2936-2944 Species denotes Patients Tax:9606
69 3200-3211 Species denotes coronavirus Tax:11118
70 2994-3002 Disease denotes COVID-19 MESH:C000657245
71 3014-3017 Disease denotes CML MESH:D015464
72 3080-3088 Disease denotes COVID-19 MESH:C000657245
73 3123-3126 Disease denotes CML MESH:D015464
77 2899-2907 Species denotes patients Tax:9606
78 2911-2919 Disease denotes COVID-19 MESH:C000657245
79 2931-2934 Disease denotes CML MESH:D015464
88 2311-2319 Species denotes patients Tax:9606
89 2455-2463 Species denotes patients Tax:9606
90 2500-2511 Species denotes coronavirus Tax:11118
91 2549-2557 Species denotes patients Tax:9606
92 2804-2812 Species denotes Patients Tax:9606
93 2307-2310 Disease denotes CML MESH:D015464
94 2451-2454 Disease denotes CML MESH:D015464
95 2836-2844 Disease denotes COVID-19 MESH:C000657245
99 4234-4242 Species denotes patients Tax:9606
100 4218-4226 Disease denotes COVID-19 MESH:C000657245
101 4230-4233 Disease denotes CML MESH:D015464
103 5400-5408 Disease denotes COVID-19 MESH:C000657245
107 5661-5669 Disease denotes coughing MESH:D003371
108 5671-5679 Disease denotes dyspnoea MESH:D004417
109 5687-5692 Disease denotes fever MESH:D005334
125 3328-3336 Species denotes patients Tax:9606
126 3382-3390 Species denotes patients Tax:9606
127 3528-3536 Species denotes patients Tax:9606
128 3780-3788 Species denotes patients Tax:9606
129 3809-3818 Species denotes SARS-CoV2 Tax:2697049
130 3948-3955 Species denotes patient Tax:9606
131 4009-4017 Chemical denotes imatinib MESH:D000068877
132 3392-3400 Disease denotes rhinitis MESH:D012220
133 3452-3460 Disease denotes coughing MESH:D003371
134 3473-3481 Disease denotes dyspnoea MESH:D004417
135 3491-3496 Disease denotes Fever MESH:D005334
136 3588-3596 Disease denotes rhinitis MESH:D012220
137 3632-3653 Disease denotes coughing and dyspnoea MESH:D003371
138 3693-3698 Disease denotes fever MESH:D005334
139 4036-4039 Disease denotes CML MESH:D015464
145 5819-5827 Species denotes patients Tax:9606
146 5886-5893 Species denotes persons Tax:9606
147 5899-5907 Species denotes patients Tax:9606
148 5945-5954 Species denotes SARS-CoV2 Tax:2697049
149 6074-6082 Species denotes patients Tax:9606
168 6374-6382 Species denotes patients Tax:9606
169 6393-6400 Species denotes patient Tax:9606
170 6515-6523 Species denotes patients Tax:9606
171 6580-6588 Species denotes patients Tax:9606
172 6638-6649 Species denotes coronavirus Tax:11118
173 6786-6795 Species denotes SARS-CoV2 Tax:2697049
174 6820-6828 Species denotes patients Tax:9606
175 6962-6970 Species denotes patients Tax:9606
176 7102-7110 Species denotes patients Tax:9606
177 6358-6366 Disease denotes COVID-19 MESH:C000657245
178 6370-6373 Disease denotes CML MESH:D015464
179 6511-6514 Disease denotes CML MESH:D015464
180 6796-6812 Disease denotes viral infections MESH:D001102
181 6816-6819 Disease denotes CML MESH:D015464
182 7093-7101 Disease denotes infected MESH:D007239
183 7281-7289 Disease denotes COVID-19 MESH:C000657245
184 7290-7299 Disease denotes infection MESH:D007239
185 7314-7317 Disease denotes CML MESH:D015464
193 7513-7520 Species denotes patient Tax:9606
194 7598-7610 Species denotes participants Tax:9606
195 7637-7645 Species denotes patients Tax:9606
196 7832-7840 Species denotes patients Tax:9606
197 7917-7924 Species denotes patient Tax:9606
198 7955-7964 Species denotes SARS-CoV2 Tax:2697049
199 7901-7908 Disease denotes anxiety MESH:D001007
211 8103-8111 Species denotes patients Tax:9606
212 8171-8180 Species denotes SARS-CoV2 Tax:2697049
213 8198-8206 Species denotes patients Tax:9606
214 8483-8491 Species denotes patients Tax:9606
215 8099-8102 Disease denotes CML MESH:D015464
216 8181-8190 Disease denotes infection MESH:D007239
217 8194-8197 Disease denotes CML MESH:D015464
218 8233-8241 Disease denotes COVID-19 MESH:C000657245
219 8370-8373 Disease denotes CML MESH:D015464
220 8419-8427 Disease denotes COVID-19 MESH:C000657245
221 8428-8437 Disease denotes infection MESH:D007239

2_test

Id Subject Object Predicate Lexical cue
32641732-32412424-66302041 927-928 32412424 denotes 2